Primary regulatory
Warning Letter: Xcel Research LLC
FDA warning letter documenting agency findings about products marketed with research-use language.
U.S. Food and Drug AdministrationPublished 2024-12-10Accessed 2026-07-12
Registry record
Source metadata
- Publisher
- U.S. Food and Drug Administration
- Source type
- Primary regulatory
- Registry ID
fda-xcel-research-warning-2024
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.